A leader from the clinical research tech specialist explains how the use of AI is increasing and outlines the many ways it could change the field.
Artificial intelligence software company Thirona has released PRAGMA-AI, technology that automates and accelerates CT scans in cystic fibrosis analysis.
While the technology has been found mostly in dermatological applications, its use in studies is expanding, according to Illingworth Research Group.
Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward.
BWXT has officially completed its acquisition of Nordion Inc., inheriting a portfolio of radioisotope products.
BioClinica has acquired MDDX Research and Informatics to provide sponsors and CROs access to medical imaging technology, which can determine patient clinical trial eligibility in under an hour, says founder.
The new Princeton, NJ-based office is the result of a multimillion-dollar investment and continued growth driven by an increasing use of medical imaging in clinical research.
Invicro has acquired Imanova in a move that bolsters the company’s biomedical imaging capabilities and gives it a foothold to expand its services into Europe.
BioClinica has opened offices in London and Munich to provide its European clients with expanded clinical trial services including medical imaging, site training and support, and eClinical product lines.
Carestream Health has offloaded most of its preclinical molecular imaging systems in a deal with Bruker.
Maccine partners on preclinical imaging lab in Singapore
Contract research organisation (CRO) Maccine will set up a preclinical imaging laboratory in partnership with the Singapore Bioimaging Consortium (SBIC) under a deal announced late last week.
Maccine opens non-human primate MRI centre
Maccine has opened a dedicated non-human primate (NHP) MRI centre to strengthen its position in translational imaging research services.
Outsourcing-pharma looks at imaging in drug development
Outsourcing-pharma takes a look at all the latest developments in the rapidly expanding drug development imaging sector with news from Aspect and Medisco, VirtualScopics and ABX-CRO and ACR Image Metrix.
Perceptive adds metrics to medical imaging reporting
Perceptive Informatics has added industry standard performance metrics to its medical imaging capabilities, allowing users to track progress against Metrics Champion Consortium (MCC) criteria.
Perceptive’s Alzheimer’s imaging aims to cut costs
Perceptive Informatics has expanded its offering for trials involving Alzheimer's disease with a new medical imaging method, which it claims produces higher quality, reproducible and regulatory compliant assessments.
Parexel’s eClinical wing inks image deal with AG Mednet
Parexel’s eClinical subsidiary Perceptive Informatics has entered into an alliance with AG Mednet to improve the efficiency and quality of the electronic image transfer process.
Charles River expands Discovery Services
Charles River Laboratories has agreed to buy US-based drug discovery imaging expert Molecular Imaging Research, Inc. (MIR) for approximately $12.5m (€8.8m) in cash.
Sanofi imaging cancer drug 'sensors'
Sanofi-Aventis is using the latest targeted imaging techniques to
assess how its cancer drugs affect organisms at the molecular
US and French medical imaging firms join
Bio-Imaging Technologies has bought French imaging firm Theralys as
it strives to broaden its clinical trial medical imaging service
VirtualScopics doubled customer base and revenue in 2005
VirtualScopics reported a breakthrough year in 2005, doubling its
customer base to 26 and reaping in more than $5 m (€4.1 m) worth of
business, an increase from the previous year of over 100 per cent.
Use of PET reduces drug R&D strain
The use of positron emission tomography (PET) and small animal
imaging has the potential to eliminate more strenuous drug
development trials with animals, creating a viable alternative.